Delivery Order SPE2DB20D1050-SPE2DB25FH53N
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,774.62, is for the delivery of lisdexamfetamine 10 mg capsules in 100-count packages. The contract has an ultimate completion date of February 11, 2025 and is a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4,567,422,819 units of 40 mg lisdexamfetamine capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4567342796 lisdexamfetamine 30 mg capsules in 100-count packages. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,465.40, is for the delivery of 4,567,836,857 units of the medication lisdexamfetamine 50 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lisdexamfetamine 60 mg capsules in 100-count packages. The contract has a firm fixed price of $7,408.93 and a completion date of June 11, 2025. This contract award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,555.08 firm fixed-price delivery order contract is for the supply of Lisdexamfetamine 30 mg capsules in 100-count packages. The contract is not set-aside and has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,355.37 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 60 mg. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 50 mg capsules in 100-count bottles, with a ceiling value of $2,836.76 and a completion date of June 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,185,890 units of the medication lisdexamfetamine 50 mg capsule in 100-count packages. The $2,584.29 firm fixed-price delivery order has a completion date of May 9, 2025 and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH53NDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,480.70, is for the delivery of lisdexamfetamine 50 mg capsules in 100-count packages. The contract is a firm fixed-price delivery order with a completion date of March 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 3/12/25 |